Lung cancer is the most common cancer in the world. Despite much progress in diagnosing and treating lung cancer patients, new solutions are needed. What are the latest scientific findings, Innovative breakthroughs and how are these effecting patients?
This program will showcase a wide range of perspectives on the current state of lung cancer, including the latest research from an academic point of view, startups making breakthroughs in treatment and prevention, and investors’ insights into future innovation opportunities. You will also here from the most important aspect, the patient.
The patient perspective: firsthand insights into a real journey.
The science: The state of genomics, micro RNA, profiling and personalization.
The Innovators: companies building out new approaches to diagnosing, preventing and fighting lung cancer.
The Investors: their latest investments in lung cancer, and where they see potential investment opportunities in the care continuum from prevention to treatment.